» Authors » A Osama Gaber

A Osama Gaber

Explore the profile of A Osama Gaber including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 167
Citations 2144
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Semaan S, Connor A, Saharia A, Kodali S, Elaileh A, Patel K, et al.
Transplant Proc . 2025 Feb; 57(2):255-263. PMID: 39939239
Background: Cholangiocarcinoma (CCA) has rising incidence and mortality rates. Outcomes from combination systemic, loco-regional therapy (LRT) and liver transplantation (LT) are improving, but more granular data are needed to inform...
2.
Soliman N, Connor A, Saharia A, Kodali S, Elaileh A, Patel K, et al.
Transplant Direct . 2025 Feb; 11(3):e1760. PMID: 39936132
Background: Perihilar cholangiocarcinoma (phCCA) has excellent outcomes following liver transplantation (LT). Neoadjuvant radiation-based locoregional therapy is standard-of-care. Gemcitabine and cisplatin (gem/cis) combination systemic therapies have improved outcomes in advanced settings,...
3.
Kaufman D, Akkina S, Stegall M, Piper J, Gaber A, Asch W, et al.
Am J Transplant . 2025 Feb; PMID: 39922283
This phase 3 multicenter, randomized, controlled clinical trial evaluated investigational cellular product (MDR-101) to produce immune tolerance vs standard of care, in kidney transplant recipients. Adult recipients of kidneys from...
4.
Hassanain H, Connor A, Brombosz E, Patel K, Elaileh A, Basra T, et al.
Transplant Direct . 2025 Jan; 11(2):e1746. PMID: 39866680
Background: Hepatocellular carcinoma (HCC) has a rising incidence and mortality in North America. Liver transplantation (LT) with adjunctive therapies offers excellent outcomes. However, HCC recurrences are associated with high mortality....
5.
Cheah Y, Yang H, Simon C, Akoad M, Connor A, Daskalaki D, et al.
Liver Transpl . 2024 Oct; 31(2):190-200. PMID: 39441028
Robotic surgery is an emerging minimally invasive option for living donor hepatectomy. Currently, there are no studies on the learning curve of robotic donor hepatectomy. Thus, we evaluated the learning...
6.
Torija A, Matignon M, Vincenti F, Casanova-Ferrer F, Pilon C, Tambur A, et al.
Am J Transplant . 2024 Aug; 25(1):88-101. PMID: 39134120
High human leukocyte antigen (HLA) sensitization limits access to compatible transplantation. New CD38-targeting agents have been shown to reduce anti-HLA antibodies, although with important interpatient variability. Thus, pretreatment identification of...
7.
Knight R, Ye Y, Graviss E, Nguyen D, Garami Z, Yi S, et al.
Clin Transplant . 2024 Jul; 38(7):e15413. PMID: 39033508
Introduction: It is unclear whether kidney/pancreas (KP) transplantation will prevent the progression of peripheral arterial disease (PAD) in patients with insulin dependent diabetes (IDDM) and end-stage renal disease. We sought...
8.
Connor A, Adelman M, Mobley C, Moaddab M, Erhardt A, Hsu D, et al.
Transplant Direct . 2024 Mar; 10(4):e1590. PMID: 38464428
Background: The COVID-19 pandemic has led to an increase in SARS-CoV-2-test positive potential organ donors. The benefits of life-saving liver transplantation (LT) must be balanced against the potential risk of...
9.
Beamish C, Lee Y, Gaber A, Chanana P, Graviss E, Kloc M, et al.
J Endocrinol . 2024 Feb; 261(1). PMID: 38305305
Metabolic syndrome (MetS) is an increasing global health threat and strong risk factor for type 2 diabetes (T2D). MetS causes both hyperinsulinemia and islet size overexpansion, and pancreatic β-cell failure...
10.
Zou D, Yin Z, Yi S, Wang G, Guo Y, Xiao X, et al.
Nat Immunol . 2024 Jan; 25(1):66-76. PMID: 38168955
CD4 T cells are central to various immune responses, but the molecular programs that drive and maintain CD4 T cell immunity are not entirely clear. Here we identify a stem-like...